Characterization of biocompatible NiCo2O4 nanoparticles for applications in hyperthermia and drug delivery

TitleCharacterization of biocompatible NiCo2O4 nanoparticles for applications in hyperthermia and drug delivery
Publication TypeJournal Article
Year of Publication2012
AuthorsKale, SN, Jadhav, AD, Verma, S, Koppikar, SJ, Kaul-Ghanekar, R, Dhole, SD, Ogale, SB
JournalNanomedicine-Nanotechnology Biology and Medicine
Volume8
Issue4
Pagination452-459
Date PublishedMAY
Type of ArticleArticle
ISSN1549-9634
KeywordsCytotoxicity, drug delivery, Magnetic hyperthermia, Magnetic nanoparticles
Abstract

Monodispersed, superparamagnetic nickel cobaltite (NCO) nanoparticles were functionalized using mercaptopropionic acid (MPA). MPA conjugates with NCO forming a metal-carboxylate linkage, with the MPA-MPA interaction occurring via formation of disulfide bonds, leaving another carboxyl end free for additional conjugation. The cytotoxicity studies on NCO-MPA show cell viability of similar to 100% up to a dosage of 40 mu g/mL on SiHa, MCF7, and B16F10 cell lines, and on mouse primary fibroblasts. Time-dependent cell viability studies done for a duration of 72 hours showed the cell lines' viability up to 80% for dosages as high as 80 mu g/mL. Negligible leaching (<5 ppm) of ionic Co or Ni was noted into the delivery medium. Upon subjecting the NCO-MPA dispersion (0.1 mg/mL) to radiofrequency absorption, the nanoparticles were heated to 75 degrees C within 2 minutes, suggesting its promise as a magnetic hyperthermia agent. Furthermore, the amino acid lysine and the drug cephalexin were successfully adducted to the NCO system, suggesting its potential for drug delivery. From the Clinical Editor: NCO-MPA nanopartciles were found to be promising magnetic hyperthermia agents, suggesting potential future clinical applications. (C) 2012 Elsevier Inc. All rights reserved.

DOI10.1016/j.nano.2011.07.010
Type of Journal (Indian or Foreign)Foreign
Impact Factor (IF)6.93
Divison category: 
Physical and Materials Chemistry